Page last updated: 2024-10-31

mitotane and Heavy Menstrual Bleeding

mitotane has been researched along with Heavy Menstrual Bleeding in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research Excerpts

ExcerptRelevanceReference
"Adrenocortical carcinoma is a rare tumour with high malignancy and poor prognosis."5.46Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane. ( Czuczwar, P; Paszkowski, T; Szkodziak, F; Szkodziak, PR; Woźniak, S, 2017)
"Adrenocortical carcinoma is a rare tumour with high malignancy and poor prognosis."1.46Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane. ( Czuczwar, P; Paszkowski, T; Szkodziak, F; Szkodziak, PR; Woźniak, S, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szkodziak, PR1
Czuczwar, P1
Woźniak, S1
Szkodziak, F1
Paszkowski, T1

Other Studies

1 other study available for mitotane and Heavy Menstrual Bleeding

ArticleYear
Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane.
    Ginekologia polska, 2017, Volume: 88, Issue:10

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Agents, Hormonal; Chemothe

2017